Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program)-Reference-Cited by-同舟云学术

Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program)

Published:2006-06 Issue:2 Volume:110 Page:242-250
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Hobbs F.D. Richard,Gensini Gianfranco,Mancini G.B. John,Manolis Athanasios J.,Bauer Beverly,Böhler Steffen,Genest Jacques,Feldman Ross,Harvey Peter,Jenssen Trond G.,Metcalfe Michael,Marques da Silva Pedro

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference42 articles.

1. Integrated management of cardiovascular risk. Report of a WHO meeting;World Health Organization,2002

2. Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group;JAMA,1982

3. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial;Lancet,2002

4. Cholesterol and mortality. 30 years of follow-up from the Framingham study;Anderson;JAMA,1987

5. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events;Greenland;JAMA,2003

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fixed-Dose Combination Medications for Treating Hypertension: A Review of Effectiveness, Safety, and Challenges;Current Hypertension Reports;2020-10-14

2. Interventions to improve the appropriate use of polypharmacy for older people;Cochrane Database of Systematic Reviews;2018-09-03

3. Efficacy and Safety of a Single-Pill Combination of Atorvastatin/Amlodipine in Patients with Arterial Hypertension and Dyslipidemia;Acta Clinica Croatica;2018

4. Fixed-dose combination orally disintegrating tablets to treat cardiovascular disease: formulation, in vitro characterization and physiologically based pharmacokinetic modeling to assess bioavailability;Drug Design, Development and Therapy;2017-03

5. Blood Pressure and Cholesterol-lowering Efficacy of a Fixed-dose Combination With Irbesartan and Atorvastatin in Patients With Hypertension and Hypercholesterolemia: A Randomized, Double-blind, Factorial, Multicenter Phase III Study;Clinical Therapeutics;2016-10